Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) EBT Margin (2018 - 2025)

Exagen's EBT Margin history spans 8 years, with the latest figure at 28.02% for Q4 2025.

  • For Q4 2025, EBT Margin fell 56.0% year-over-year to 28.02%; the TTM value through Dec 2025 reached 29.89%, down 275.0%, while the annual FY2025 figure was 29.89%, 275.0% down from the prior year.
  • EBT Margin reached 28.02% in Q4 2025 per XGN's latest filing, up from 41.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 19.69% in Q2 2024 to a low of 192.87% in Q2 2022.
  • Average EBT Margin over 5 years is 55.12%, with a median of 40.73% recorded in 2023.
  • Peak YoY movement for EBT Margin: plummeted -14269bps in 2022, then skyrocketed 15741bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 54.2% in 2021, then plummeted by -117bps to 117.76% in 2022, then surged by 66bps to 40.25% in 2023, then skyrocketed by 32bps to 27.46% in 2024, then dropped by -2bps to 28.02% in 2025.
  • Per Business Quant, the three most recent readings for XGN's EBT Margin are 28.02% (Q4 2025), 41.09% (Q3 2025), and 25.59% (Q2 2025).